Vir Biotechnology Inc V.VIR

Primary Symbol: VIR

Healthcare Biotechnology

Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.

NDAQ:VIR - Post by User

Vir Biotechnology Inc > 8.5 centz...Down on Volume??? EWe!!!

<< Previous

Bullboard Posts

Next >>

Post by Sophia123on Nov 13, 2020 10:18am

775 Views

Post# 31894575

8.5 centz...Down on Volume??? EWe!!!

Hi EVERYONE!!!!! I jus noticed that the shares of ExperionHoldings Ltd where down this morining after LANGUISHING at 9 centz and low low volume.

Is it TAX LOSS selling season settin in???

Mediocer quarter in a saturated market with even the big playerz in trouble all over the space.

Thingz are NOT lookin to good here huh??? This bull board blog is about to be FILLED with big hairey bagholderz lashin out at EVERY.THING...

I dunno.

Have the BEST day EVERYONE!!!! ^_^